SCHEMBL3469404

SCHEMBL3469404

COc1ccc(I)n2nc(C3(CN)CC3)nc12

nearest known ligand 0.47

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 9/20 0.47
PDE4A P27815 11/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL510059 0.88 PDE4A (0.59) PDE4DPDE4A
SCHEMBL509081 0.80 PDE4D (0.47) PDE4DPDE4A
SCHEMBL3469402 0.79 PDE4A (0.58) PDE4DPDE4A
SCHEMBL509408 0.77 JAK2 (0.45) PDE4DPDE4A
SCHEMBL17571398 0.77 PDE4D (0.48) PDE4DPDE4A
SCHEMBL508221 0.77 PDE4D (0.59) PDE4DPDE4A
SCHEMBL509744 0.75 PDE4D (0.43) PDE4DPDE4A
SCHEMBL7042523 0.74 PDE10A (0.44) PDE4D
SCHEMBL17571377 0.74 PDE4A (0.60) PDE4DPDE4A
SCHEMBL3469983 0.73 PDE4D (0.84) PDE4DPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379548-B1 TRIAZOLOPYRIDINES AS PHOSPHODIESTERASE INHIBITORS FOR TREATMENT OF DERMAL DISEASES LEO PHARMA AS (DK) 2016-03-09 EP disclosed
US-8952162-B2 Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases LEO PHARMA A/S (DK) 2015-02-10 US disclosed
WO-2010069322-A1 TRIAZOLOPYRIDINES AS PHOSPHODIESTERASE INHIBITORS FOR TREATMENT OF DERMAL DISEASES LEO PHARMA A/S (DK) 2010-06-24 WO disclosed